Chromothripsis and progression-free survival in metastatic colorectal cancer.

Mol Clin Oncol · 2017 · PMC5351707 · PMID 28357089

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

In patients with detected chromothripsis and CEA ≤5.5 ng/ml (n=4), a median PFS (mPFS) of 22.5 months was observed; in patients without chromothripsis and elevated CEA level (n=7), an mPFS of 8 months was observed, but these findings did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.